How many years should you take lorlatinib/lorlatinib for the longest time?

Lorlatinib (Lorlatinib) A is a prescription drug used to treat adults with non-small cell lung cancer (NSCLC), which is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and has spread to other parts of the body. Doctors will conduct tests to make sure lorlatinib is right for patients. It's not yet known whether lorlatinib is safe and effective in children.

Lorlatinibis a third-generation targeted drug targeting ALK gene rearrangement. Its duration of use varies depending on the patient's specific situation, including the development stage of the disease, patient tolerance and response to the drug. Generally speaking, there is no fixed maximum number of years of treatment with lorlatinib, but in clinical practice, many patients may continue to use the drug until disease progression or unacceptable side effects occur.

In clinical trials, the efficacy and safety of lorlatinib have been fully verified, and many patients can achieve cancer tumor shrinkage or disease stabilization after taking the drug. In some studies, some patients were able to maintain a good quality of life under long-term use of lorlatinib without obvious resistance. This means that for patients who can tolerate the drug and benefit from it, it can be used for a longer period of time.

However, while patients are taking lorlatinib, doctors will conduct regular evaluations to monitor treatment effects and side effects. If a patient's disease progresses or drug-resistant mutations develop, other treatment options may need to be considered. In addition, patients may experience some side effects during long-term use of lorlatinib, such as hypercholesterolemia, fatigue, weight gain, and central nervous system-related discomfort. These factors will also affect the duration of treatment.